CG Oncology (CGON) Other Non Operating Income (2023 - 2026)
CG Oncology (CGON) reported Other Non Operating Income of -$101000.0 for Q1 2026, down 2120.0% on a YoY basis from $5000.0 in Q1 2025, and down 90.57% quarter-over-quarter from -$53000.0 in Q4 2025.
CG Oncology (CGON) Other Non Operating Income (2023 - 2026) Analysis & Trends
CG Oncology has reported Other Non Operating Income for 4 years, with the latest figure at -$101000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income fell 2120.0% year-over-year to -$101000.0; the trailing twelve-month figure through Mar 2026 stood at -$258000.0 (down 1617.65% YoY), and the FY2025 full-year result was -$152000.0, down 5166.67% from the prior year.
- Other Non Operating Income for Q1 2026 stood at -$101000.0, down from -$53000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $8000.0 in Q1 2023, with the low at -$101000.0 in Q1 2026.
- Historically, Other Non Operating Income has averaged -$24000.0 across 4 years, with a median of -$4000.0 in 2023.
- Annual changes were most pronounced in 2024 — Other Non Operating Income jumped 250.0% — and 2025, when it plunged 4900.0%.
- CG Oncology's Other Non Operating Income stood at -$4000.0 in 2023, then jumped by 250.0% to $6000.0 in 2024, then sank by 983.33% to -$53000.0 in 2025, then slumped by 90.57% to -$101000.0 in 2026.
- The last three Other Non Operating Income figures came in at -$101000.0 (Q1 2026), -$53000.0 (Q4 2025), and -$100000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | CG Oncology | 5.16 Bn | 5.16 Bn | -1.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -101,000.00 |
| Dec 31, 2025 | -53,000.00 |
| Sep 30, 2025 | -100,000.00 |
| Jun 30, 2025 | -4,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Sep 30, 2024 | -2,000.00 |
| Jun 30, 2024 | 8,000.00 |
| Mar 31, 2024 | -9,000.00 |
| Dec 31, 2023 | -4,000.00 |
| Sep 30, 2023 | -8,000.00 |
| Jun 30, 2023 | -58,000.00 |
| Mar 31, 2023 | 8,000.00 |